| Non‐small cell lung cancer in China P Chen, Y Liu, Y Wen, C Zhou Cancer Communications 42 (10), 937-970, 2022 | 31 | 2022 |
| Quantitative Proteomic Analysis of Plasma after Remote Ischemic Conditioning in a Rhesus Monkey Ischemic Stroke Model S Song, L Guo, D Wu, J Shi, Y Duan, X He, Y Liu, Y Ding, X Ji, R Meng Biomolecules 11 (8), 1164, 2021 | 5 | 2021 |
| The Negative Prognostic Role of Inflammatory Biomarkers in Patients With Chronic Cerebrospinal Venous Insufficiency S Song, D Lan, B Jiao, Y Liu, Y Ding, X Ji, R Meng The Neurologist, 10.1097, 2022 | 3 | 2022 |
| Innate lymphoid cells exhibited IL-17-expressing phenotype in active tuberculosis disease L Pan, X Chen, X Liu, W Qiu, Y Liu, W Jiang, Y Zheng, Y Mou, W Xu, X Li, ... BMC pulmonary medicine 21 (1), 1-11, 2021 | 3 | 2021 |
| Use of Batroxobin in Central and Peripheral Ischemic Vascular Diseases: A Systematic Review D Lan, S Song, Y Liu, B Jiao, R Meng Frontiers in neurology 12, 2021 | 3 | 2021 |
| Potential anti-inflammatory and anti-coagulation effects of one-time application of remote ischemic conditioning in patients with subacute/chronic cerebral arteriostenosis and … S Song, B Jiao, D Lan, Y Liu, S Wan, Y Guo, Y Ding, X Ji, R Meng The Neurologist 27 (6), 324-332, 2022 | 2 | 2022 |
| Remote ischemic conditioning-induced hyperacute and acute responses of plasma proteome in healthy young male adults: a quantitative proteomic analysis S Song, H Wu, Y Liu, D Lan, B Jiao, S Wan, Y Guo, D Zhou, Y Ding, X Ji, ... Chinese Medical Journal 136 (02), 150-158, 2023 | | 2023 |
| The Combined Value of Type2 Inflammatory Markers in Chronic Obstructive Pulmonary Disease Y Liu, G Ma, Y Mou, X Liu, W Qiu, Y Zheng, H Zhu, H Ge Journal of Clinical Medicine 11 (10), 2791, 2022 | | 2022 |
| Progress in immunologic and genetic research of chronic obstructive pulmonary disease with lung cancer YH Liu, HY Ge, HL Zhu Zhonghua jie he he hu xi za zhi= Zhonghua Jiehe he Huxi Zazhi= Chinese …, 2022 | | 2022 |
